Clinical Trial Update: An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma [Phase 3]

View source ↗

Summary

An early access (compassionate use) study of ivosidenib for patients with pretreated cholangiocarcinoma (locally advanced or metastatic) is in Phase 3 and curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Ivosidenib (ivosidenib)

Snippet

Sponsor: Servier Affaires Médicales | Conditions: Cholangiocarcinoma | Phase 3 | Status: RECRUITING